A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children
With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase
Does the drug Apixaban prevent blood clots in children with leukemia or lymphoma?
Basic Study Information
Purpose:Location: University Of Rochester General Clinical Research Center
The purpose of this study is to compare the effect of a blood thinning drug called
versus no administration of a blood thinning drug, in preventing blood clots in children
leukemia or lymphoma. Patients must be receiving chemotherapy, including asparaginase,
have a central line (a catheter inserted for administration of medications and blood
Study Contact InformationStudy Coordinator: Angela Girvin, Site 0064
Phone: (585) 275-5839
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search